Cargando…

Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided High Dose Rate brachytherapy boost

PURPOSE: To report early observation of transient PSA elevations on this pilot study of external beam radiation therapy and magnetic resonance imaging (MRI) guided high dose rate (HDR) brachytherapy boost. MATERIALS AND METHODS: Eleven patients with intermediate-risk and high-risk localized prostate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Anurag K, Guion, Peter, Susil, Robert C, Citrin, Deborah E, Ning, Holly, Miller, Robert W, Ullman, Karen, Smith, Sharon, Crouse, Nancy Sears, Godette, Denise J, Stall, Bronwyn R, Coleman, C Norman, Camphausen, Kevin, Ménard, Cynthia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564026/ https://www.ncbi.nlm.nih.gov/pubmed/16914054 http://dx.doi.org/10.1186/1748-717X-1-28

Ejemplares similares

Intra- and inter-radiation therapist reproducibility of daily isocenter verification using prostatic fiducial markers
por: Ullman, Karen L, et al.
Publicado: (2006)

Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study
por: Singh, Anurag K, et al.
Publicado: (2007)

Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas
por: Stall, Bronwyn, et al.
Publicado: (2010)

A dosimetric comparison of four treatment planning methods for high grade glioma
por: Zach, Leor, et al.
Publicado: (2009)

Accuracy of 3D volumetric image registration based on CT, MR and PET/CT phantom experiments
por: Li, Guang, et al.
Publicado: (2008)

Boost in radiotherapy: external beam sunset, brachytherapy sunrise
por: Maciejewski, Boguslaw
Publicado: (2009)

Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy
por: Liu, Yuan, et al.
Publicado: (2020)

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost
por: Panettieri, Vanessa, et al.
Publicado: (2020)

Correction of motion‐induced misalignment in co‐registered PET/CT and MRI (T1/T2/FLAIR) head images for stereotactic radiosurgery
por: Li, Guang, et al.
Publicado: (2010)

Post-collection,pre-measurement variables affecting VEGF levels in urine biospecimens
por: Hayward, Robert M, et al.
Publicado: (2008)

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens
por: Kirk, M J, et al.
Publicado: (2008)

Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique
por: Morton, Gerard C.
Publicado: (2014)

Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas
por: Cortesi, Annalisa, et al.
Publicado: (2017)

Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal
por: Bertin, Emilien, et al.
Publicado: (2018)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost
por: Embring, Anna, et al.
Publicado: (2023)

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
por: Belliveau, C., et al.
Publicado: (2022)

Early Experiences of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Treatment in Localized Prostate Cancer
por: Ko, Christine, et al.
Publicado: (2012)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
por: Smolska-Ciszewska, Beata, et al.
Publicado: (2015)

External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison
por: Terheyden, Martje Marie, et al.
Publicado: (2016)

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020)

Automated position and size selection of round applicators for AccuBoost breast brachytherapy
por: West, Foster L., et al.
Publicado: (2020)

Registering prostate external beam radiotherapy with a boost from high-dose-rate brachytherapy: a comparative evaluation of deformable registration algorithms
por: Moulton, Calyn R., et al.
Publicado: (2015)

A comparative study of high-dose-rate brachytherapy boost combined with external beam radiation therapy versus external beam radiation therapy alone for high-risk prostate cancer
por: Oshikane, Tomoya, et al.
Publicado: (2021)

Endoscope-Guided Interstitial Intensity-Modulated Brachytherapy and Intracavitary Brachytherapy as Boost Radiation for Primary Early T Stage Nasopharyngeal Carcinoma
por: Wan, Xiang-Bo, et al.
Publicado: (2014)

CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy
por: Haas, Jonathan Andrew, et al.
Publicado: (2012)

Tumor bed boost in breast cancer: Brachytherapy versus electron beam
por: Roy, Sanjoy, et al.
Publicado: (2013)

Interstitial high-dose rate brachytherapy as boost for anal canal cancer
por: Falk, Alexander Tuan, et al.
Publicado: (2014)

Brachytherapy boost after chemoradiation in anal cancer: a systematic review
por: Frakulli, Rezarta, et al.
Publicado: (2018)

Image-guided interstitial brachytherapy boost for nasopharyngeal carcinoma: technical aspects
por: Murakami, Naoya, et al.
Publicado: (2020)

What pelvic radiation disease symptoms are experienced by patients receiving external beam radiotherapy and a high-dose-rate brachytherapy boost for prostate cancer?
por: Halkett, Georgia K.B., et al.
Publicado: (2017)

Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia
por: Ong, Wee Loon, et al.
Publicado: (2022)

Future directions of in vivo dosimetry for external beam radiotherapy and brachytherapy
por: Verhaegen, Frank, et al.
Publicado: (2020)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Clinical results of external beam radiotherapy alone with a concomitant boost program or with conventional fractionation for cervical cancer patients who did not receive intracavitary brachytherapy
por: Matsuura, Kanji, et al.
Publicado: (2012)

Pulsed dose rate brachytherapy as the boost in combination with external beam irradiation in base of tongue cancer. Long-term results from a uniform clinical series
por: Johansson, Bengt, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gvm23t9mrbsvnr9gc4lpaamlg0